IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals

Reuters

07-30

IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals

IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2555804320"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555804320\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2555804320?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-30 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555804320","market":"nz","top_or_hot":-1,"title":"IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-30 19:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDLC0gzc:1","article_id":"2555804320","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555804320","pubTimestamp":1753873365,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx Cellular Analyzer and IDEXX Cancer Dx testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurat","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK4567":"ESG概念","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","BK4504":"桥水持仓","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU1941712348.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","BK4585":"ETF&股票定投概念","BK4588":"碎股","IDXX":"爱德士实验室","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC"},"translate_title":"IDEXX Laboratories发布2024年企业责任报告，详细介绍ESG目标进展","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IDXX":0.9},"content_text":"IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n    \n\n        IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}